Contemporary Management of Valvular Disease: Diagnosis, Imaging, and Intervention

presented by Cleveland Clinic

6 others would like to attend.

I need an invite

Notification icon Friday, September 6, 2019 7 AM - Saturday, September 7, 2019 12:30 PM America/New_York

Location Icon InterContinental Boston, Boston, MA

Event info

Register HERE!

The diagnosis, imaging, and treatment of heart valve disease is constantly evolving, highlighted by innovations in techniques, devices, and imaging. In addition, research studies and clinical trials are continually expanding the evidence base related to patient assessment and treatment outcomes from valve interventions, both transcatheter- and surgically implanted devices. These developments, in turn, have altered the clinical practice framework for approaching both mitral and aortic valve disease quantification and treatments resulting in some confusion regarding the optimal management strategies. As the research continues, the volume and complexity of the data being generated make it difficult for busy practitioners to remain up to date on their knowledge and practices. As a result, some patients with valve disease may receive less than optimal care.

This program is designed to bring together cardiologists, surgeons and other healthcare providers to review and analyze new research and technical advances and assesses their potential impact on clinical practice.

Target Audience:

Cardiologists, cardiothoracic surgeons, interventional cardiologists, internists, nurses, physician assistants and all healthcare professionals involved in the evaluation, diagnosis and management of patients with valve disease

Learning Objectives:

  • Summarize advances in imaging technology for quantifying the severity of mitral regurgitation and describe current recommendation for grading the disease.
  • Present the pros and cons of mitral valve repair vs replacement, techniques, and minimally invasive approaches.
  • Describe strategies for treating uncommon developments associated with degenerative mitral valves including tricuspid repair, atrial fibrillation ablation, and Barlow’s valve repair.
  • Describe the decision-making approach to the management of functional mitral valves including whether to repair or replace.
  • Demonstrate knowledge of most recent technologies and techniques for transcatheter repair and replacement of valves.
  • Detail trends in transcatheter versus surgical aortic valve replacement.
  • Summarize the options for diagnosis and treatment of tricuspid valve disease.

Cleveland Clinic has ranked as the nation’s #1 heart care program for 24 consecutive years by U.S. News & World Report.

Upcoming live Cleveland Clinic CME activities for cardiovascular specialists:

Course Syllabus

Click HERE to view the syllabus

6 others would like to attend.

I need an invite

Login to view comments. Click here to Login